534 related articles for article (PubMed ID: 27995696)
1. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
[TBL] [Abstract][Full Text] [Related]
2. Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Bódi B; Kovács Á; Gulyás H; Mártha L; Tóth A; Mátyás C; Barta BA; Oláh A; Merkely B; Radovits T; Papp Z
Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829647
[TBL] [Abstract][Full Text] [Related]
3. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
5. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
Kolijn D; Pabel S; Tian Y; Lódi M; Herwig M; Carrizzo A; Zhazykbayeva S; Kovács Á; Fülöp GÁ; Falcão-Pires I; Reusch PH; Linthout SV; Papp Z; van Heerebeek L; Vecchione C; Maier LS; Ciccarelli M; Tschöpe C; Mügge A; Bagi Z; Sossalla S; Hamdani N
Cardiovasc Res; 2021 Jan; 117(2):495-507. PubMed ID: 32396609
[TBL] [Abstract][Full Text] [Related]
7. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus.
Mátyás C; Németh BT; Oláh A; Hidi L; Birtalan E; Kellermayer D; Ruppert M; Korkmaz-Icöz S; Kökény G; Horváth EM; Szabó G; Merkely B; Radovits T
Cardiovasc Diabetol; 2015 Oct; 14():145. PubMed ID: 26520063
[TBL] [Abstract][Full Text] [Related]
8. The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus.
Radovits T; Bömicke T; Kökény G; Arif R; Loganathan S; Kécsán K; Korkmaz S; Barnucz E; Sandner P; Karck M; Szabó G
Br J Pharmacol; 2009 Mar; 156(6):909-19. PubMed ID: 19298393
[TBL] [Abstract][Full Text] [Related]
9. Targeting Phosphodiesterase-5 by Vardenafil Improves Vascular Graft Function.
Veres G; Hagenhoff M; Schmidt H; Radovits T; Loganathan S; Bai Y; Korkmaz-Icöz S; Brlecic P; Sayour AA; Karck M; Szabó G
Eur J Vasc Endovasc Surg; 2018 Aug; 56(2):256-263. PubMed ID: 29724533
[TBL] [Abstract][Full Text] [Related]
10. Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
Primessnig U; Schönleitner P; Höll A; Pfeiffer S; Bracic T; Rau T; Kapl M; Stojakovic T; Glasnov T; Leineweber K; Wakula P; Antoons G; Pieske B; Heinzel FR
Eur J Heart Fail; 2016 Aug; 18(8):987-97. PubMed ID: 27135883
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4.
Hamdani N; Hervent AS; Vandekerckhove L; Matheeussen V; Demolder M; Baerts L; De Meester I; Linke WA; Paulus WJ; De Keulenaer GW
Cardiovasc Res; 2014 Dec; 104(3):423-31. PubMed ID: 25341892
[TBL] [Abstract][Full Text] [Related]
12. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
[TBL] [Abstract][Full Text] [Related]
13. Shunxin decoction improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway.
Jiaying Z; Xiangxiang W; Xuefeng LI; Yang Y; Yinghuan D; Yanbin S; Ping X; Mengru Z; Junnan Z; Miao LI; Shuwen Z; Rui Z; Ying T; Hao T; Feifei T
J Tradit Chin Med; 2022 Oct; 42(5):764-772. PubMed ID: 36083484
[TBL] [Abstract][Full Text] [Related]
14. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
[TBL] [Abstract][Full Text] [Related]
15. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
16. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
17. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.
Daniels A; Linz D; van Bilsen M; Rütten H; Sadowski T; Ruf S; Juretschke HP; Neumann-Haefelin C; Munts C; van der Vusse GJ; van Nieuwenhoven FA
Eur J Heart Fail; 2012 Feb; 14(2):193-201. PubMed ID: 22253456
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of Na
Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
[TBL] [Abstract][Full Text] [Related]
19. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
20. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
